SELEXYS PHARMACEUTICALS CORP — Form D/A
SELEXYS PHARMACEUTICALS CORP of OKLAHOMA CITY, OK, a company, filed a Form D amendment with the SEC on 2015-02-23. The offering totals $43.2M, of which $43.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-02-23
- Form: D/A
- Accession: 0001140361-15-008408
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $43.2M
- Amount sold: $43.2M
- Minimum investment: $13K
- Investors: 57
- Date of first sale: 2012-09-17
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-184899
Issuer
- Name: SELEXYS PHARMACEUTICALS CORP
- CIK: 0001442824
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 840 RESEARCH PARKWAY, OKLAHOMA CITY, OK, 73104
- Phone: 405-319-8198
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Todd Foley | Director | South San Francisco, CA |
| Philip Jones, M.D. | Director | Norman, OK |
| David Keiser | Director | Madison, CT |
| Rodger McEver, M.D. | Director | OKLAHOMA CITY, OK |
| Scott Rollins, Ph.D. | Director | OKLAHOMA CITY, OK |
| Richard Alvarez | Executive Officer | Phoenix, AZ |
| David Falconer | Executive Officer | Edmond, OK |
| Scott Rollins, Ph.D. | Executive Officer | OKLAHOMA CITY, OK |
| Russell Rother | Executive Officer | Oklahoma City, OK |
| William Paiva | Director | Broken Arrow, OK |
| Tom Walker | Director | FRISCO, TX |
| Philip Jones | Director | Oklahoma City, OK |
| Scott Rollins | Director | Oklahoma City, OK |
| Scott Rollins | Executive Officer | Oklahoma City, OK |
| William Paiva, Ph.D. | Director | Tulsa, OK |
| Rodger McEver | Director | Oklahoma City, OK |
Other filings by this issuer (5)
More